| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |